Carpenter Technology Partner to Commercialize new Class of Metal Alloys

Carpenter Technology Corporation (NYSE:CRS) and Manhattan Scientifics Inc. (OTC BB: MHTX) announced today a joint technology agreement involving a new class of high strength metals with broad applications in medical, aerospace, transportation, energy, defense and consumer products.

Manhattan Scientifics holds the exclusive U.S. license for a family of patents to produce super-strong metals developed at the Los Alamos National Laboratory and in Russia. Carpenter, a leading steel and specialty alloys manufacturer, will develop, manufacture and market the new generation of advanced metals.

"Carpenter continues to forge ahead as the leading developer of stainless steels and specialty alloys," said Anne L. Stevens, Carpenter's chairman and chief executive officer. "Our relationship with Manhattan Scientifics will ultimately give us new, cutting edge manufacturing techniques that we can apply to many of our alloys to service an increasing global need for high strength materials"

Manhattan Scientifics' CEO Manny Tsoupanarias said, "Carpenter Technology Corporation is exactly the kind of industrial manufacturing partner that can bring our new class of metals to the broad market. The initial technology transfer payments along with eventual royalties from Carpenter will provide Manhattan Scientifics quick and sustained revenue, positive cash flow and profitability beginning this year. This is a major break-through for our 8,600 shareholders."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.